SCTB-41 / Sinocelltech - LARVOL DELTA

SCTB35 and SCTB41 With or Without Chemotherapy in Non-Hodgkin Lymphoma (clinicaltrials.gov) - P1/2 | N=90 | Not yet recruiting | Sponsor: Sinocelltech Ltd.

New P1/2 trial • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology

SCTB41 Plus SCTB39G With or Without Standard Therapy in Advanced Solid Tumors (clinicaltrials.gov) - P1/2 | N=112 | Not yet recruiting | Sponsor: Sinocelltech Ltd.

New P1/2 trial • Oncology • Solid Tumor

SCTB41 Combined With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer (clinicaltrials.gov) - P2/3 | N=410 | Recruiting | Sponsor: Sinocelltech Ltd.

New P2/3 trial • Lung Cancer • Lung Non-Small Cell Squamous Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • ALK • EGFR • PD-L1

A Clinical Study of SCTB41 Combined With Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer（Phase II Study Ongoing） (clinicaltrials.gov) - P2 | N=90 | Not yet recruiting | Sponsor: Sinocelltech Ltd.

New P2 trial • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor

Phase I/II Study of SCTB41 Plus SCTB39-1with or Without Standard Therapy in Advanced Solid Tumours (clinicaltrials.gov) - P1/2 | N=126 | Not yet recruiting | Sponsor: Sinocelltech Ltd.

New P1/2 trial • Oncology • Solid Tumor

Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB41 in Adult Patients with Advanced Malignant Solid Tumours. (clinicaltrials.gov) - P1/2 | N=441 | Recruiting | Sponsor: Sinocelltech Ltd. | Not yet recruiting ➔ Recruiting

Enrollment open • Oncology • Solid Tumor

Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB41 in Adult Patients With Advanced Malignant Solid Tumours. (clinicaltrials.gov) - P1/2 | N=441 | Not yet recruiting | Sponsor: Sinocelltech Ltd.

Metastases • New P1/2 trial • Oncology • Solid Tumor